All News Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

Market Closed - Nasdaq Other stock markets 16:30:01 2024-05-14 EDT			5-day change	1st Jan Change
2.88 ^USD	-8.57%		+1.41%	-14.03%

05-07	Cyclerion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-05	Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cyclerion Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-07	CI
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
Cyclerion Appoints Regina Graul, Ph.D., as President	12-04	AQ
Cyclerion Therapeutics, Inc. Appoints Regina Graul as President	12-04	CI
Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator	11-30	AQ
Cyclerion Therapeutics, Inc. Announces Board of Directors Appointments	11-30	CI
Cyclerion Therapeutics, Inc. Announces Resignation of Ole Isacson as Director	11-24	CI
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Cyclerion Therapeutics, Inc. Announces Anjeza Gjino Resigns as Chief Financial Officer	23-10-23	CI
Cyclerion Therapeutics, Inc. - Tisento Launches with $81 Million from Top-Tier Investor Syndicate and Promising Cyclerion Assets	23-08-01	AQ
Cyclerion Therapeutics Acquires 10% Stake in Tisento Therapeutics in Asset Purchase Deal	23-07-31	MT
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets	23-07-31	AQ
Tisento Therapeutics, Inc. announced that it has received $81 million in funding from Cyclerion Therapeutics, Inc., Invus, Polaris, and other investors	23-07-30	CI
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-28	CI
Cyclerion Therapeutics, Inc. Announces Resignation of Cheryl Gault as Chief Operating Officer	23-06-27	CI
CYCLERION THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-06-01	AQ
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement	23-06-01	AQ
Cyclerion Therapeutics : Private Placement - Form 8-K	23-05-25	PU
CYCLERION THERAPEUTICS, INC. : Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-05-25	AQ
Cyclerion Therapeutics, Inc. announced that it has received $5.000001 million in funding	23-05-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Cyclerion Therapeutics, Inc.

Equities

CYCN

US23255M2044

All News

Filters